IL-32 supports the survival of malignant T cells in cutaneous T cell lymphoma. Yu KK, Smith NP, Essien SV, Teague JE, et al. J Invest Dermatol 2022 Feb 7. pii: S0022-202X(22)00019.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu KK, Smith NP, Essien SV, Teague JE, et al. IL-32 supports the survival of malignant T cells in cutaneous T cell lymphoma. J Invest Dermatol 2022 Feb 7. pii: S0022-202X(22)00019.
PMID: 35143819